[Pulmonary fibrosis and endovesical mitomycin C].
José M Janeiro Pais1, Vicente Pastor Casas Agudo, Daniel López Garcia
1Servicio de Urología, Hospital Juan Canalejo, La Coruña, España. janeiropais@canalejo.org
Actas Urologicas Espanolas
|September 18, 2009
Summary
Mitomycin C, used for bladder cancer, can cause rare but fatal lung disease. This case highlights a severe respiratory adverse effect from endovesical instillation, even when considered safe.
Area of Science:
- Oncology
- Pulmonology
- Pharmacology
Background:
- Mitomycin C is a chemotherapeutic agent utilized for various carcinomas.
- It has been administered via endovesical instillations for superficial bladder carcinoma for over 25 years.
- Systemic administration is associated with known adverse effects like myelosuppression and pulmonary fibrosis.
Observation:
- A patient developed a respiratory illness consistent with interstitial lung disease.
- This condition progressed to severe respiratory insufficiency.
- The patient ultimately died following endovesical Mitomycin C administration.
Findings:
- The presented case details a fatal respiratory illness following endovesical Mitomycin C instillation.
- This adverse effect, interstitial lung disease leading to death, is exceptionally rare for this route of administration.
- The findings suggest a potential for severe pulmonary toxicity even with localized drug delivery.
Implications:
- This case underscores the importance of vigilance for rare but severe adverse effects of Mitomycin C.
- It prompts further investigation into the mechanisms of pulmonary toxicity from endovesical chemotherapy.
- Clinicians should consider the potential for severe respiratory complications in patients receiving endovesical Mitomycin C.
More Related Videos
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...